You are here

  • Home
  • Archive
  • Volume 14, Issue 7
  • Presumed complement-mediated, checkpoint inhibitor-induced, thrombotic microangiopathy in a patient with metastatic melanoma

Article info

Article menu
Download PDFPDF
Case report
Presumed complement-mediated, checkpoint inhibitor-induced, thrombotic microangiopathy in a patient with metastatic melanoma

Authors

  1. Correspondence to Dr Thiago P. Muniz; thiago.muniz{at}uhn.ca
View Full Text

Citation

Muniz TP, Patriquin CJ, Saibil SD
Presumed complement-mediated, checkpoint inhibitor-induced, thrombotic microangiopathy in a patient with metastatic melanoma
BMJ Case Reports CP 2021;14:e242075.

Publication history

  • Accepted July 12, 2021
  • First published July 26, 2021.
Online issue publication 
July 26, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.